"No material deficiency notices (FDA's clock hasn't stopped for soft tissue or vitiligo)"
I don't believe they "stop the clock" under breakthrough, it's done with a different approach. Keeping this in mind, listenimg to the calls, CEo alludes to maybe having contact to the FDA about something. But all my speculation.
Ann: Q1 2023 Investor Presentation, page-108
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.68 |
Change
0.020(0.75%) |
Mkt cap ! $183.5M | |||
| Open | High | Low | Value | Volume |
| $2.68 | $2.68 | $2.64 | $62.30K | 23.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4020 | $2.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.67 | 1416 | 3 |
View Market Depth
| Last trade - 11.49am 29/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |